Hexagon Capital Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-96
Closed -$22.3K – 992
2025
Q1
$22.3K Sell
96
-100
-51% -$24.3K ﹤0.01% 719
2024
Q4
$44.9K Sell
196
-66
-25% -$15.1K 0.01% 514
2024
Q3
$58.6K Sell
262
-13
-5% -$2.86K 0.01% 419
2024
Q2
$56K Sell
275
-10
-4% -$2.03K 0.01% 412
2024
Q1
$62.3K Hold
285
– – 0.01% 387
2023
Q4
$64.8K Sell
285
-14
-5% -$2.94K 0.02% 354
2023
Q3
$60.1K Sell
299
-53
-15% -$11.2K 0.02% 326
2023
Q2
$72.9K Sell
352
-7
-2% -$1.36K 0.02% 297
2023
Q1
$70.7K Sell
359
-38
-10% -$7.82K 0.02% 296
2022
Q4
$80.3K Sell
397
-31
-7% -$6.06K 0.02% 267
2022
Q3
$75K Buy
428
+5
+1% +$1.02K 0.02% 292
2022
Q2
$85K Hold
423
– – 0.03% 282
2022
Q1
$96K Hold
423
– – 0.03% 283
2021
Q4
$114K Hold
423
– – 0.03% 248
2021
Q3
$102K Sell
423
-2
-0.5% -$504 0.03% 244
2021
Q2
$101K Buy
425
+15
+4% +$3.42K 0.03% 249
2021
Q1
$89K Sell
410
-1
-0.2% -$201 0.02% 242
2020
Q4
$71K Hold
411
– – 0.02% 234
2020
Q3
$73K Buy
+411
New +$65.1K 0.02% 212

Other funds holding LH

Hexagon Capital Partners's LH Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Labcorp (LH) in Q2 2025, closing a stake of 96 shares — an estimated $22.3K sold.

Hexagon Capital Partners first reported a position in LH in Q3 2020 and held it in 19 quarters. The position peaked at $114K in Q4 2021. 975 funds tracked by Wall St. Rank hold LH as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Labcorp position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 96 Labcorp shares in Q2 2025, an estimated $22.3K.
  • Hexagon Capital Partners first reported a position in Labcorp in Q3 2020 and held it in 19 quarters.
  • Hexagon Capital Partners's Labcorp position peaked at $114K in Q4 2021.
  • 975 funds tracked by Wall St. Rank held Labcorp as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.